Wegovy and Ozempic contain the exact same active ingredient, semaglutide, made by the same manufacturer (Novo Nordisk). The core difference is what they’re approved to treat and how much you take. Ozempic is FDA-approved for type 2 diabetes management, while Wegovy is approved for chronic weight management in adults with obesity or overweight with at least one weight-related health condition. That distinction shapes nearly everything else: the dosing, the cost, and whether your insurance will pay for it.
Same Drug, Different Purpose
Semaglutide mimics a natural gut hormone called GLP-1 that regulates appetite and blood sugar. When you inject it once a week, it slows digestion, reduces hunger signals in the brain, and helps the pancreas release insulin more effectively. Both medications do all of these things because they are, at the molecular level, identical.
The distinction is purely regulatory. Ozempic went through clinical trials focused on blood sugar control in people with type 2 diabetes. Wegovy went through a separate set of trials focused on weight loss in people with obesity. This matters because FDA approval dictates how doctors can prescribe the drug and, critically, how insurers decide whether to cover it.
Dosing Is the Biggest Practical Difference
Wegovy tops out at a higher dose than Ozempic. Ozempic’s maximum maintenance dose is 2 mg per week, while Wegovy’s is 2.4 mg per week. That 0.4 mg gap might sound small, but it reflects the different treatment goals. Weight management typically requires a stronger appetite-suppressing effect than blood sugar control alone.
Both medications use a gradual dose escalation schedule to reduce side effects. You start at a low dose and increase roughly every four weeks until you reach the target. With Wegovy, that climb takes about 16 to 20 weeks as you step through five dose levels (0.25 mg, 0.5 mg, 1 mg, 1.7 mg, then 2.4 mg). Ozempic follows a similar but shorter path, typically moving from 0.25 mg to 0.5 mg, then optionally to 1 mg or 2 mg.
Weight Loss Results
Because Wegovy delivers a higher dose and was specifically studied for weight loss, its clinical trial data reflects more dramatic results. In the STEP 10 trial, participants taking Wegovy’s 2.4 mg dose lost an average of 13.9% of their body weight over 52 weeks. For someone weighing 220 pounds, that translates to roughly 30 pounds in a year.
Ozempic also causes significant weight loss, which is why many doctors have prescribed it off-label for that purpose. But its pivotal trials (the SUSTAIN series) measured blood sugar improvement as the primary outcome, with weight loss tracked as a secondary benefit. At Ozempic’s lower maximum dose, the weight loss effect is generally more modest than what Wegovy achieves at 2.4 mg.
Side Effects Are Similar but Dose-Dependent
Since both drugs are semaglutide, they share the same side effect profile. The most common complaints are gastrointestinal: nausea, vomiting, diarrhea, constipation, and bloating. These tend to be worst during the first few weeks at each new dose level and improve as your body adjusts.
The gradual dose escalation exists specifically to minimize these effects. Jumping straight to the full dose would make nausea far more severe. Because Wegovy ultimately reaches a higher dose, some people experience more intense or prolonged GI symptoms during the later stages of titration. Starting low and staying at each dose for about four weeks before stepping up gives the body time to adapt.
The Pens Work Differently
Ozempic comes as a multi-dose pen. Each pen holds enough medication for four or eight weekly injections depending on your prescribed strength. You attach a new disposable needle before each injection and turn a dial to select your dose. Between uses, you store the pen in the refrigerator or at room temperature for up to 56 days.
Wegovy uses single-use, prefilled pens. Each pen comes with the needle already attached and delivers one fixed dose. You use it once and throw it away. Wegovy pens can be kept outside the refrigerator for up to 28 days (as long as the temperature stays between 46°F and 86°F), which is half the room-temperature window Ozempic allows. If you travel frequently or don’t always have refrigerator access, that difference in storage flexibility is worth noting.
Insurance Coverage Varies Dramatically
This is where the same-drug-different-label situation creates the most frustration. Because Ozempic is classified as a diabetes medication, most insurance plans cover it for people with a type 2 diabetes diagnosis, often after a prior authorization. Coverage is relatively straightforward if you meet that criteria.
Wegovy faces a much steeper coverage battle. Most private insurance companies and federal health programs do not cover weight-loss drugs. Medicare has been explicitly prohibited by law from covering weight-loss treatments since 2003. Even private insurers that technically cover obesity medications frequently impose strict requirements: documented BMI thresholds, evidence of failed diet and exercise programs, or enrollment in a supervised weight management plan.
This coverage gap is why many people with obesity end up using Ozempic off-label for weight loss instead of Wegovy. A doctor can legally prescribe Ozempic for weight management, but insurance will only cover it if the prescription is tied to a diabetes diagnosis. Without insurance, both drugs cost over $1,000 per month at retail price, though manufacturer savings programs and pharmacy discount cards can reduce out-of-pocket costs in some cases.
Which One Gets Prescribed and Why
If you have type 2 diabetes, your doctor will likely start with Ozempic. It controls blood sugar effectively, and you’ll lose weight as a secondary benefit. If you also have obesity, you may eventually discuss switching to Wegovy for the higher dose, though insurance logistics can complicate that transition.
If your primary concern is weight loss and you don’t have diabetes, Wegovy is the FDA-approved option. Getting it covered is the challenge. Your doctor may need to submit detailed documentation to your insurer, and approval can take weeks. Some people pay out of pocket while waiting, or explore manufacturer patient assistance programs.
The drugs are not interchangeable at the pharmacy level. Even though both contain semaglutide, a prescription for Ozempic cannot be filled with Wegovy and vice versa. They have different National Drug Codes, different pen designs, and different dosing increments, so your doctor needs to write the specific prescription that matches your treatment plan and insurance situation.